Stefan F Lichtenthaler Selected Research

4- amino- 5- chloro- 2,3- dihydrobenzofuran- 7- carboxylic acid (3- hydroxy- 1- (3- methoxypropyl)piperidin- 4ylmethyl)amide

7/2013

Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan F Lichtenthaler Research Topics

Disease

66	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 03/2003
5	Amyloid Plaque 01/2022 - 05/2010
5	Neoplasms (Cancer) 01/2021 - 02/2013
4	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021 - 01/2019
3	Infections 01/2022 - 04/2013
3	Amyloidosis 01/2022 - 01/2016
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/2021 - 07/2010
3	Inflammation (Inflammations) 10/2021 - 03/2006
3	Multiple Sclerosis 11/2020 - 01/2015
3	Mental Disorders (Mental Disorder) 01/2020 - 08/2019
2	CADASIL 01/2022 - 01/2018
2	Vesicular Stomatitis 10/2021 - 12/2018
2	Arthritis (Polyarthritis) 01/2017 - 02/2013
2	Cognitive Dysfunction 01/2016 - 06/2006
2	Brain Diseases (Brain Disorder) 01/2016 - 12/2015
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 06/2015 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 01/2015
2	Neuroblastoma 07/2013 - 11/2011
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2013 - 07/2008
1	Familial Cerebral Amyloid Angiopathy 01/2022
1	COVID-19 01/2022
1	Synucleinopathies 01/2022
1	Autism Spectrum Disorder 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 10/2021
1	Psychotic Disorders (Schizoaffective Disorder) 11/2020
1	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2020
1	Central Nervous System Diseases (CNS Diseases) 10/2020
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 01/2018
1	Lymphoma (Lymphomas) 01/2018
1	Tauopathies 01/2017
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2017
1	Schizophrenia (Dementia Praecox) 01/2016
1	Neuroinflammatory Diseases 01/2016
1	Gliosis 01/2016
1	Disease Progression 01/2015
1	Neoplasm Metastasis (Metastasis) 12/2014
1	Frontotemporal Dementia (Semantic Dementia) 03/2013
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2013
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 03/2013
1	Parkinson Disease (Parkinson's Disease) 03/2013
1	Rheumatoid Arthritis 02/2013
1	Carcinoma (Carcinomatosis) 01/2013

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2003
44	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2003
23	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 01/2006
22	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022 - 05/2004
20	Peptides (Polypeptides)IBA 01/2020 - 05/2004
20	Amyloid beta-PeptidesIBA 01/2020 - 03/2003
14	Pharmaceutical PreparationsIBA 01/2022 - 06/2010
11	EnzymesIBA 01/2018 - 12/2004
8	Metalloproteases (Metalloproteinases)IBA 01/2022 - 01/2011
6	Aspartic Acid ProteasesIBA 01/2019 - 12/2003
4	ProteomeIBA 01/2022 - 01/2018
3	Membrane Proteins (Integral Membrane Proteins)IBA 02/2022 - 03/2006
3	Glycoproteins (Glycoprotein)IBA 10/2021 - 01/2013
3	PrionsIBA 10/2021 - 04/2013
3	LigandsIBA 10/2021 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 06/2015
2	CholesterolIBA 12/2021 - 07/2010
2	LipidsIBA 10/2021 - 01/2021
2	Protein AggregatesIBA 10/2021 - 04/2013
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
2	CytokinesIBA 01/2021 - 02/2013
2	DisintegrinsIBA 01/2020 - 01/2016
2	Immunoglobulin G (IgG)IBA 06/2015 - 01/2015
2	Transcription Factors (Transcription Factor)IBA 04/2011 - 06/2006
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2021
1	2-5A-dependent ribonuclease (RNase L)IBA 01/2021
1	AutoantibodiesIBA 11/2020
1	AntigensIBA 01/2019
1	Hemagglutinins (Hemagglutinin)IBA 12/2018
1	Neuraminidase (Sialidase)IBA 12/2018
1	Biological ProductsIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	annonacinIBA 01/2017
1	Tissue Inhibitor of Metalloproteinase-3IBA 01/2017
1	NeurotoxinsIBA 01/2017
1	Tiopronin (Thiola)FDA Link 02/2016
1	SynaptophysinIBA 01/2016
1	tau Proteins (tau Protein)IBA 01/2016
1	PresenilinsIBA 01/2016
1	Presenilin-1IBA 01/2016
1	Sirtuin 2IBA 01/2016
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 06/2015
1	TACI receptor-IgG Fc fragment fusion proteinIBA 01/2015
1	Catechin (Z 7300)IBA 01/2015
1	nardilysinIBA 01/2014
1	5-HT4 Serotonin ReceptorsIBA 07/2013
1	4- amino- 5- chloro- 2,3- dihydrobenzofuran- 7- carboxylic acid (3- hydroxy- 1- (3- methoxypropyl)piperidin- 4ylmethyl)amideIBA 07/2013
1	prucaloprideIBA 07/2013
1	Neuregulin-1 (Neuregulin 1)IBA 05/2013
1	FilaminsIBA 03/2013
1	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2013
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 03/2013
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2013
1	Epithelial Cell Adhesion MoleculeIBA 01/2013

Therapy/Procedure

1	Immunotherapy 12/2018
1	Therapeutics 01/2017